Test my supply
64%
Finnrick rating
#240 of 301 ranked vendors
54 of 74 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Allen Biotechnology Co ABC's Purity focus record is product-split: Retatrutide is strongest and Tesamorelin has improved, while Tirzepatide is uneven and BPC-157 remains weak. Evidence is recent and broad, but confidence is limited by missing batch IDs, fill swings, and thin files at the low-volume end.

methodology →
vendor intelligence report
Vendor Intelligence Report: Allen Biotechnology Co ABC

A dissolved UK namesake, absent storefront domain, Cloudflare-blocked forum anchor, and Telegram rebrand reshape Allen's public identity trail. The report also traces crypto-only payment rails, US warehouse logistics, and an unresolved tirzepatide dispute.

24 pages7 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$1.10
90%
14
2
Tirzepatide
$0.33
76%
38
3
PT-141
$0.60
66%
4
4
Tesamorelin
$1.45
58%
9
5
BPC-157
-
36%
5
6
TB-500
$1.05
33%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%4 Feb 2026: 53%4 Feb 2026: 53%4 Feb 2026: 54%4 Feb 2026: 53%4 Feb 2026: 54%4 Feb 2026: 54%11 Feb 2026: 55%11 Feb 2026: 55%15 Feb 2026: 56%16 Feb 2026: 56%18 Feb 2026: 55%18 Feb 2026: 55%18 Feb 2026: 55%18 Feb 2026: 55%18 Feb 2026: 54%19 Feb 2026: 54%20 Feb 2026: 55%20 Feb 2026: 54%25 Feb 2026: 55%25 Feb 2026: 55%26 Feb 2026: 55%26 Feb 2026: 56%1 Mar 2026: 56%1 Mar 2026: 57%2 Mar 2026: 57%4 Mar 2026: 61%4 Mar 2026: 61%6 Mar 2026: 61%6 Mar 2026: 61%12 Mar 2026: 62%23 Apr 2026: 62%23 Apr 2026: 62%28 Apr 2026: 62%11 May 2026: 62%11 May 2026: 63%4 Jun 2026: 63%12 Jun 2026: 64%26 Jun 2026: 64%17 Jul 2026: 64%3 Aug 2026: 64%10 Aug 2026: current 64%53%62%64%Feb 26Aug 26
Test my supply
Allen Biotechnology Co ABC test history
COA-backed lab tests
1-10 of 74

About Allen Biotechnology Co ABC test results from Finnrick

Allen Biotechnology Co ABC is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 74 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Allen Biotechnology Co ABC peptides in this dataset are Retatrutide (14 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 74 recent tests.

Corrections
No corrections.
Test my supply